| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 37.475 | 30.111 | 121.884 | 212.621 | 229.554 | 311.694 | 350.438 | 340.446 | 408.076 |
| Total Income - EUR | 0 | 37.475 | 65.137 | 121.885 | 212.624 | 229.557 | 311.695 | 350.502 | 340.450 | 408.472 |
| Total Expenses - EUR | 1.991 | 37.017 | 62.049 | 119.030 | 206.768 | 211.485 | 275.855 | 314.921 | 355.274 | 403.089 |
| Gross Profit/Loss - EUR | -1.991 | 457 | 3.088 | 2.855 | 5.856 | 18.072 | 35.840 | 35.582 | -14.824 | 5.383 |
| Net Profit/Loss - EUR | -1.991 | 384 | 2.803 | 1.637 | 3.730 | 16.147 | 33.097 | 32.602 | -17.597 | -6.258 |
| Employees | 1 | 2 | 5 | 11 | 13 | 11 | 15 | 14 | 14 | 14 |
Check the financial reports for the company - Lumiclinic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 14.837 | 12.705 | 39.005 | 40.943 | 45.508 | 44.456 | 41.600 | 68.583 |
| Current Assets | 79 | 17.515 | 21.727 | 37.912 | 27.718 | 14.899 | 44.360 | 102.888 | 96.185 | 41.629 |
| Inventories | 0 | 0 | 3.704 | 9.102 | 6.254 | 92 | 9.350 | 24.523 | 39.601 | 1.621 |
| Receivables | 0 | 16.701 | 17.418 | 18.869 | 17.531 | 23.176 | 25.732 | 52.674 | 44.397 | 17.583 |
| Cash | 79 | 814 | 605 | 9.941 | 3.933 | -8.369 | 9.278 | 25.692 | 12.187 | 22.425 |
| Shareholders Funds | -1.946 | -1.542 | 1.286 | 2.985 | 6.700 | 22.720 | 49.249 | 82.004 | 64.158 | 57.541 |
| Social Capital | 45 | 45 | 44 | 129 | 169 | 165 | 162 | 162 | 162 | 161 |
| Debts | 2.025 | 19.057 | 35.278 | 47.632 | 60.024 | 33.123 | 40.620 | 65.341 | 73.627 | 52.671 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Lumiclinic Srl